Home›Warfarin›Warfarin + Aspirin And Extended Release Dipyridamole

Does Warfarin Interact with Aspirin And Extended Release Dipyridamole?

CDI records a major classification for Warfarin and Aspirin And Extended Release Dipyridamole. The stored summary is: Aspirin displaces warfarin from protein binding sites, leading to prolongation of prothrombin time and bleeding time. The mechanism involves displacement from protein binding sites. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity
Major
Aspirin And Extended Release Dipyridamole Class
Nonsteroidal Anti-inflammatory Drug
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

Recorded Mechanism

Displacement from protein binding sites

What To Tell Your Doctor or Pharmacist

If you are taking Warfarin and your doctor is considering prescribing Aspirin And Extended Release Dipyridamole (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Warfarin(Warfarin Sodium)+💊 Aspirin And Extended Release Dipyridamole(Aspirin And Extended - Release Dipyridamole Capsules, 25 Mg / 200 Mg)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
—
Drug B class
Nonsteroidal Anti-inflammatory Drug
Source
NLP:aspirin and extended-release dipyridamole

What this means in plain English

Aspirin displaces warfarin from protein binding sites, leading to prolongation of prothrombin time and bleeding time.

About Warfarin and Aspirin And Extended Release Dipyridamole

Aspirin And Extended Release Dipyridamole is a Nonsteroidal Anti-inflammatory Drug. Warfarin additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:aspirin and extended-release dipyridamole

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Warfarin and Aspirin And Extended Release Dipyridamole against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations